PHILADELPHIA — Performance measurement is one way to help eliminate racial disparities in health care, Dr. John Z. Ayanian said at the annual meeting of the American College of Physicians.
Public and private payers must also do their part by maintaining accurate and complete data on race and ethnicity to help monitor disparities, said Dr. Ayanian, associate professor of medicine and health care policy at Harvard Medical School in Boston.
There has been some success in narrowing the racial care gap in areas with widespread measurement. For example, a study published last year found both overall quality improvement in the use of β-blockers after acute myocardial infarction among Medicare managed-care beneficiaries and a significant narrowing of the racial gap in treatment. The treatment gap between black and white beneficiaries had been 12% in 1997 and fell to 0.4% in 2002 (N. Engl. J. Med. 2005;353:692–700).
But there is still work to do, he said. For example, the same study shows that while overall quality improved in cholesterol control for coronary artery disease, the racial disparity is actually increasing in that measure. The study showed that the gap for cholesterol control, defined as LDL cholesterol below 130 mg/dL after discharge, between black and white patients was 13% in 1999 and widened to 16% in 2002.
Lack of trust and/or communication between minority patients and physicians also are factors in care disparity, Dr. Ayanian said. Many physicians don't recognize that past discrimination in health care, such as the Tuskegee syphilis study, still fuels minorities' mistrust of the health care system, he said.
A cooperative national study that was conducted by Dr. Ayanian and his colleagues looked at new patient preferences for renal transplantation among end-stage renal disease patients ages 18 to 54 in Michigan, Alabama, Southern California, and the Washington metropolitan area in 1996–1997.
The researchers found small differences in the patient preferences for the transplant but larger differences in the referral for evaluation. For example, 86% of white men favored transplantation, and 82% were referred for evaluation. However, 81% of black men favored transplantation but only 58% were referred for evaluation (N. Engl. J. Med. 1999;341:1661–9).
In addition, most patients in the study said they agreed with and trusted their physician. But white patients were more likely to trust and agree with physicians than black patients, and black patients received less information about transplantation.
Physicians, researchers, and policy makers need to work together to help eliminate disparities, Dr. Ayanian said. Expanded research funding is needed to better evaluate the causes of disparities and financial incentives from payers can be used to reward “equitable and high-quality” care, he said.